Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanand Sarkar

Showing results (271-280 of 273) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 273 results.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 28

Showing results (271-280 of 273) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 273 results.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 28